Volume 53; Issue 5

Cancer Immunology, Immunotherapy

Volume 53; Issue 5

1

Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA

Benoît Barrou, Gérard Benoît, Mahmoud Ouldkaci, Olivier Cussenot, Margarita Salcedo, Sudhanshu Agrawal, Séverine Massicard, Nadège Bercovici, MatsL. Ericson, Nicolas Thiounn

Journal:

Cancer Immunology, Immunotherapy

Year:

2004

Language:

english

File:

PDF, 224 KB

english, 2004

2

In vivo priming of natural killer T cells by dendritic cells pulsed with hepatoma-derived acid-eluted substances

Ritsuko Ishii, Masumi Shimizu, Yohko Nakagawa, Kazuo Shimizu, Shigeo Tanaka, Hidemi Takahashi

Journal:

Cancer Immunology, Immunotherapy

Year:

2004

Language:

english

File:

PDF, 318 KB

english, 2004

3

Effect of albumin fusion on the biodistribution of interleukin-2

Zhengsheng Yao, Weili Dai, James Perry, MartinW. Brechbiel, Cynthia Sung

Journal:

Cancer Immunology, Immunotherapy

Year:

2004

Language:

english

File:

PDF, 340 KB

english, 2004

4

Identification of a MHC class-II restricted epitope in carcinoembryonic antigen

Lei Shen, Roland Schroers, Juergen Hammer, XueF. Huang, Si-Yi Chen

Journal:

Cancer Immunology, Immunotherapy

Year:

2004

Language:

english

File:

PDF, 402 KB

english, 2004

5

Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck

Journal:

Cancer Immunology, Immunotherapy

Year:

2004

Language:

english

File:

PDF, 227 KB

english, 2004

6

Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies

PamelaJ. Russell, Dean Hewish, Teresa Carter, Katy Sterling-Levis, Kim Ow, Meghan Hattarki, Larissa Doughty, Robin Guthrie, Deborah Shapira, PeterL Molloy, JeromeA. Werkmeister, AlexanderA. Kortt

Journal:

Cancer Immunology, Immunotherapy

Year:

2004

Language:

english

File:

PDF, 340 KB

english, 2004

7

Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display

Alexander Fosså, Lene Alsøe, Reto Crameri, Steinar Funderud, Gustav Gaudernack, ErlendB. Smeland

Journal:

Cancer Immunology, Immunotherapy

Year:

2004

Language:

english

File:

PDF, 371 KB

english, 2004

8

Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3

DeanneM.R. Lathers, JosephI. Clark, NicholasJ. Achille, M.RitaI. Young

Journal:

Cancer Immunology, Immunotherapy

Year:

2004

Language:

english

File:

PDF, 442 KB

english, 2004

9

Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B

Hyoung-Ran Kim, Hyun-Joo Park, JeonHan Park, SeJong Kim, Kunhong Kim, Jongsun Kim

Journal:

Cancer Immunology, Immunotherapy

Year:

2004

Language:

english

File:

PDF, 610 KB

english, 2004

10

Polyclonal T-cell activation protocol stimulates preferential expansion of EBV-specific T-cell clones in vitro

IdaAagård Hedfors, JanE. Brinchmann

Journal:

Cancer Immunology, Immunotherapy

Year:

2004

Language:

english

File:

PDF, 208 KB

english, 2004

11

Further development of local IL-2 therapy of cancer: multiple versus single IL-2 treatment of transplanted murine colon carcinoma

Halina Kusnierczyk, Elzbieta Pajtasz-Piasecka, Jan-Willem Koten, Caspaar Bijleveld, Krzysztof Krawczyk, Willem Otter

Journal:

Cancer Immunology, Immunotherapy

Year:

2004

Language:

english

File:

PDF, 1.82 MB

english, 2004

12

British Society for Immunology annual congress, Harrogate, UK, 2–5 December 2003

Journal:

Cancer Immunology, Immunotherapy

Year:

2004

Language:

english

File:

PDF, 109 KB

english, 2004